The results of a 5-year longitudinal prospective study about the health-related quality of life (HRQL) of pediatric patients receiving allogeneic bone marrow or stem cell transplantation (BMT) are described. The patients' HRQL was assessed twice before, and five times after BMT, the end point being 1 year after BMT. For the measurement of HRQL, standardized questionnaires were completed by patients, parents and physicians. The final sample consisted of 68 patients aged 4-18 years, of which 19 were lost in the course of the study owing to relapse, transplant rejection and/or death. The worst HRQL was seen shortly after transplant and HRQL thereafter improved steadily, although the improvement was not always linear and not all patients drew benefit from this average positive evolution. Compromised emotional functioning, a high level of worry and reduced communication during the acute phase of treatment had a negative impact on HRQL 1 year after BMT. Nausea and pain during the acute phase of treatment did not have an effect on later HRQL. The interobserver agreement of HRQL reports between parents and their children was moderate to good, and generally better than child-physician and parentphysician agreement.
Introduction
Allogeneic bone marrow and stem cell transplantations (BMTs) are among the most frequent major organ transplants and their therapeutic applications may be extended to more conditions and diseases in the future.
As more patients receive and survive BMT, the consideration of health-related quality of life (HRQL) issues becomes increasingly important.
Much of the evidence on HRQL after BMT comes from survivors who are years post transplantation. Some studies showed that pediatric patients who survived a couple of years were likely to achieve a reasonable adjustment and satisfactory HRQL. [1] [2] [3] Other studies suggest that pediatric BMT recipients are at risk of developing long-term emotional or social problems. 4, 5 Continued HRQL research is necessary because children undergoing treatment on current protocols do not receive the same therapy as those from whom the 'evidence' has been obtained and such details may alter the long-term impact of the therapy. 6 There have been practical changes in the administration of therapy and improvements in treatment protocols, such as the introduction of reduced-intensity conditioning, 7 that may have led to less adverse side effects and a better HRQL.
Studies that employ a prospective longitudinal design measuring HRQL, both before and at multiple time points after transplantation, are rare. Therefore, little is known about the response of patients during the acute phase of treatment and the months following. Kupst et al. 8 assessed psychosocial functioning of pediatric BMT recipients before, 1 year and 2 years after BMT using the Child Behavior Checklist. Overall, they found a low prevalence of behavioral and social problems, stability in functioning over time and pre-BMT functioning strongly predictive of later functioning. The study of Barrera et al. 9 suggests an improvement of HRQL in children 6 months after BMT as compared to pre-BMT. The most comprehensive work was presented by Phipps et al. 10 They developed a specific measure for the assessment of behavioral, affective and somatic experiences during the acute phase of BMT -the BASES. In 2002, they published the results of a study including 153 children undergoing allogeneic or autologous stem cell transplantation. 11 The children were assessed at the time of admission for transplant, then underwent weekly assessments to week þ 6, followed by monthly assessments to month þ 6. Phipps et al.'s 10 findings can be summarized as follows: the patients entered the hospital with an already compromised HRQL worsening dramatically until about a week following BMT. Thereafter, HRQL steadily improved until the end point, with some declines in specific HRQL domains at month þ 2 or þ 3. The trajectories of distress depicted by parent and child reports were very similar. Predictors of HRQL-related distress were matched unrelated donor transplant (as compared to matched sibling or autologous transplant), older age and lower socioeconomic status of patients. 12 Such findings are important as they can be provided as information to the families before the transplant so that their expectations for recovery after treatment are more realistic. Further, they can be used to plan specific interventions for the time when the patients and/or families may need them most.
Here, we report our results of a 5-year longitudinal prospective study in pediatric patients receiving BMT at different transplant centers. As compared to the study of Phipps et al., 10 we excluded patients receiving autologous stem cell or bone marrow transplantation and extended the observation period until 1 year after BMT. For this reason, we used HRQL instruments also suitable for the time when patients reintegrate into normal routines and social functioning.
Specific research questions addressed were: What is the course of HRQL from the time before BMT until 1 year after transplantation? Is HRQL at 1 year after BMT better than HRQL pre-BMT and better than at 6 months post transplant? Which HRQL problems during hospitalization have an impact on HRQL at 1 year post transplant? and finally, Are the assessments of the patients' HRQL consistent among different observers, that is, patients, parents and physicians?
Patients and methods

Patients
All consecutively treated patients seen in four pediatric transplant centers in Austria and the Switzerland were eligible for the study if they were German speaking and 3 years of age or older. Subject enrolment was scheduled to take 4 years with the aim of reaching a sample size of about 70 patients. Of all eligible patients, about 10% of patients and/or parents declined to participate, resulting in a sample size of 68 patients. Sociodemographic and medical characteristics of patients are given in Table 1 .
Patients were assessed seven times: 4-6 weeks (TÀ35) and 7 days (TÀ7) before BMT, and 10 (T þ 10), 28 (T þ 28), 100 (T þ 100), 180 (T þ 180) and 360 (T þ 360) days after BMT. Of the 68 patients, we lost 19 (27.9%) in the course of the study because of rejection of the transplant, relapse and/or death: one (1.5%) before TÀ7, one (1.5%) before T þ 10, four (5.9%) before T þ 28, six (8.8%) before T þ 100, five (7.3%) before T þ 180 and two (2.9%) before T þ 360. One patient (1.5%) dropped out before T þ 10 for personal reasons.
At TÀ35, instead of 68 patients and families, only 36 (52.9%) could be assessed. This is because no medical consultation had been arranged for that date or because patients had not yet been admitted to the transplant center by this time.
HRQL assessment and measures
Before enrolment, patients and families were informed extensively about the study and signed a consent form meeting all institutional and state guidelines. Approval of the study protocol was gained from the institutional review boards before commencement of the study.
For the assessment of HRQL, we used two established standardized measures, both of North American origin, with which we were familiar owing to prior research in childhood cancer survivors undertaken at one of the participating institutions. These measures were the Pediatric Quality of Life Inventoryt (PedsQLt) and the Health Utilities Index Mark2 þ 3 (HUI2/3):
The PedsQLt is based on a modular approach to measuring HRQL in children and teenagers from 2 to 18 years of age. [13] [14] [15] The 23-item generic core measure (version 4.0) consists of scales assessing level of physical, emotional, social and school functioning. The cancer module (version 3.0) includes 27 items that cover the domains of pain, nausea, procedural anxiety, treatment anxiety, worry, cognitive problems, perceived physical appearance and communication. 15, 16 The PedsQLt items ask about the frequency of problems that occurred during a certain period of time. Item responses are measured on a five-point rating scale ranging from 'never' to 'almost always'. The total score of a scale is calculated as the average of the [17] [18] [19] [20] The HUI2 classification system consists of the seven attributes: sensation, mobility, emotion, cognition, selfcare, pain and fertility. The HUI3 system evolved from the HUI2 and has eight attributes: vision, hearing, speech, ambulation, dexterity, emotion, cognition and pain. Conceptually, HUI2 and HUI3 are based on functional capacity rather than on performance and on a 'within the skin' approach. Each attribute is represented by one or two questions and each question offers four to six response options. These options correspond to descriptive phrases that range from normal to very poor functioning. The systems further offer the possibility of providing singlesummary utility scores indicating HRQL on a scale from 0 (representing the utility of death) to 1 (representing the utility of perfect health). For the calculation of global utility scores of HUI2 and HUI3, multi-attribute values and formulas are available. For depicting the HUI total score, we used the average of the HUI2 and the HUI3 global utility score. As the attributes of the HUI2/3 refer to well observable domains of functioning, the instrument is fairly well suited to the assessment from various viewpoints. That is why we used the HUI2/3 for the children's, parents' and physicians' assessments of the child's HRQL.
At the measurement time points TÀ35, T þ 180 and T þ 360, our questionnaires included all scales of the generic core and cancer-specific PedsQLt and all items of the HUI2/3 and a recall period of 1 month. At the time points TÀ7, T þ 10, T þ 28 and T þ 100, at which patients were staying in the transplant center or living at home, respectively, patients and parents were asked to respond only to items that were appropriate for patients under very intensive treatment, that is, the items of the PedsQLt scales emotional functioning, pain, nausea, worry and communication, and the items emotion, pain and cognition of the HUI2/3. Physicians were asked to complete all 15 items of the HUI2/3 at all measurement time points. At TÀ35, T þ 100, T þ 180 and T þ 360, we included a self-designed item in the HUI2/3 questionnaire addressing eating problems, as these are often observed in patients after BMT. This item, however, was not considered in the calculation of the HUI total score.
The PedsQLt was administered to the children with a minimum age of 6 years and to all resident parents ( ¼ the ones staying with their child during hospitalization) at all measurement time points, and to the second parents at TÀ35 and T þ 360. The HUI2/3 was administered to children with a minimum age of 10 years, to all resident parents and to the physicians at all measurement time points as well as to the second parents at TÀ35 and T þ 360.
The PedsQLt and the HUI2/3 contain 3 scales/items each enquiring about emotional issues and pain. To better differentiate those six domains, we renamed them as follows:
'Emotional functioning' (PedsQLt): addresses feelings of anxiety, sadness, and anger, sleeping problems and worries about the future. 'Psychological well-being' (HUI3): addresses feelings of unhappiness. 'Mood disturbance' (HUI2): addresses feelings of fretfulness, anger, irritability, anxiety and depression. 'Pain FREQ ' (PedsQLt): addresses the frequency of pain in joints and/or muscles as well as strong pain. 'Pain ACT ' (HUI3): addresses pain that prevents activities. 'Pain MED þ ACT ' (HUI2): addresses pain that has to be relieved by medication and disrupts activities.
Statistical analyses
During data collection, we noticed that at specific time points, some patients refused to complete the HRQL questionnaires. Those missing data were corrected for, using multiple imputation techniques. Each missing childreport scale score was predicted from the parent-report scale score of the relevant time point and the child-and parent-report scale scores of the preceding and subsequent time points. To give a simple example: at T þ 28, the childreport score of patient no. 24 was missing for 'worry'. In this patient, the mean difference between child-and parentreport scores at T þ 10 and T þ 100 was À6, and at T þ 28, the parent-report score for 'worry' was 70. Thus, we inserted the score 76 for the missing child-report score at T þ 28. We used this technique for seven missing child reports at T þ 10, five missing child reports at T þ 28 and four missing child reports at T þ 100. At all other time points, all questionnaires handed over to the children were completed and returned.
Descriptive statistical analyses were performed to compute scale score means, s.d.'s and ranges. Paired t-tests were used to analyze the differences between two time points. To determine which HRQL deficits during intensive therapy and hospitalization (TÀ7, T þ 10, T þ 28) had an impact on HRQL 1 year later, we performed regression and correlation analyses.
To test for interobserver agreement between children/ adolescents, parents and physicians, we performed intraclass correlation (ICC) analyses. ICC is a measure of proportion of overall variability accounted for by variability among individuals. Regarding the interpretation of ICC values, we could not find uniquely agreed guidelines. For alternative measures like Pearson's product-moment correlation, it has been generally agreed that correlations of o0.30 indicate poor, correlations between 0.30 and 0.50 moderate and those above 0.50 good agreement. 21 We therefore decided to adhere to this interpretation guideline, provided that the ICC values were not substantially different from the Pearson's correlation values. Further, we used paired t-tests to determine which HRQL scores of the child reports were significantly higher or lower than the scores of the parent and physician reports.
Because of multiple significance testing, we chose a P-value of p0.01 to provide statistical significance.
Results
To examine whether it was justified also to use the data of patients who were lost in the course of the study for our analyses, we compared HRQL scores of the two groups. At five of seven time points, the two groups were big enough for comparison. The analyses revealed only two significant differences: in the lost patients, the HUI total score was significantly lower at T þ 100, and the scale score of emotional functioning was significantly higher at TÀ35. We therefore decided to use all collected data for our analyses.
Descriptive statistics of HRQL scores revealed the following: the full range of possible HRQL scores (0-100 in the PedsQLt and 0.00-1.00 in the HUI2/3) was observed for physical functioning at TÀ35; emotional functioning at T þ 180; pain FREQ at TÀ35, T þ 10 and T þ 100; nausea at TÀ35; procedural anxiety at TÀ35 and T þ 180; worry at TÀ35, TÀ7, T þ 10, T þ 28 and T þ 180; perceived physical appearance at TÀ35; communication at TÀ35, T þ 10, T þ 28, T þ 100, T þ 180; pain ACT at TÀ35, T þ 10, T þ 28 and T þ 180; self-care at TÀ35; pain MED þ ACT at T þ 10,
T þ 28 and T þ 180; and eating problems at T þ 180. Additionally, the lowest possible HRQL score (0) was seen in emotional functioning at TÀ35 and nausea at TÀ7 and T þ 10. As a group, the patients demonstrated a distinct decline in all HRQL domains and all assessments at T þ 10 with a steady improvement until T þ 360 and some minor declines in various HRQL domains at different time points (see graphical depictions of the trajectories at Figure 1) .
This means that although HRQL improved steadily for the majority of patients after T þ 10, there were patients who had the worst possible HRQL in specific domains in at least one of three subsequent time points (T þ 28, T þ 100, T þ 180). On the other hand, there were also patients who had the best possible HRQL in specific domains in at least one of all time points after T þ 10.
To determine whether HRQL was better at 1 year after BMT as compared to pre-BMT, we compared the most important HRQL scores assessed at TÀ35, TÀ7 and T þ 360. Results are given in Table 2 . In all analyzed HRQL domains except for pain, HRQL was better at T þ 360 as compared to the two measurement time points before BMT. For worry and functional capacity (HUI total score), the differences between TÀ35 and T þ 360 just failed to reach statistical significance. As can be seen in Figure 1 , HRQL did not change much between T þ 180 and T þ 360. In some domains and assessments, a slight improvement was observable, in others a slight decline, but none of these changes was statistically significant. The only exception was emotional functioning in the parent reports, which significantly improved between T þ 180 and T þ 360. Of the domains not depicted in the graphs on Figure 1 , physical functioning and procedural anxiety in the parent reports showed a significant change to the better.
To evaluate whether specific HRQL problems during hospitalization had an impact on HRQL 1 year post transplant, we performed regression analyses using HRQL scores collected during hospitalization as predictors for HRQL at T þ 360. These potential predictor variables were emotional functioning, pain, nausea, worry and communication. Only variables that showed a significant result in at least two of the three time points TÀ7, T þ 10 and T þ 28 were considered to have a predictive value.
Emotional functioning during the acute phase of treatment (description see 'Patients and methods') was a significant predictor for physical functioning, social functioning and generic HRQL in the parent reports of T þ 360. Worry during the acute phase of treatment (includes items addressing worries about effectiveness and side effects of treatment, and fears of a relapse) was a significant predictor for physical functioning and worry in the child reports of T þ 360 and for worry in the parent reports of T þ 360. Communication in the acute phase of treatment (includes items addressing the ability to talk about one's feelings and about the disease, and asking nurses and physicians questions) was a significant predictor for worry, perceived physical appearance and communication in the child reports of T þ 360. Pain and nausea during the acute phase of treatment did not predict HRQL at T þ 360.
The results of interobserver agreement analyses are summarized in Table 3 . At the majority of time points, the agreement between parents and their children was moderate to good, with the exception of communication, in which children and parents demonstrated only poor agreement throughout the study. At the time when the HRQL of patients was the worst (T þ 10), the agreement between parents and their children was the best. Generally, parental ratings of the child's HRQL were lower than children's ratings in a number of HRQL domains throughout the study (of which 27% of mean score comparisons reached statistical significance). The HRQL scores collected from physicians were generally lower than the children's scores but higher than the parents' scores, although without being significantly different in the majority of HRQL domains. The agreement between children and physicians was rather poor at TÀ7, T þ 10 and T þ 100, whereas it ranged equally from poor to good at all other time points. The agreement between physicians and parents was also poor at TÀ7 and T þ 10, but better at all other time points than child-physician agreement. In the majority of domains, the resident parent and the second parent agreed well on the child's HRQL at time points TÀ35 and T þ 360.
Discussion
This study has attempted to describe the HRQL of pediatric patients receiving BMT by using two standardized measures and the assessments from the different viewpoints of patients, parents and physicians. Data collection was performed at two time points before BMT and five time points after BMT with 1 year post transplant being the end point. Table 2 Improvement of HRQL after BMT: differences between HRQL at 1 year post transplant (T+360) compared to HRQL before BMT (TÀ35 and TÀ7)
HRQL-domain
Paired score differences between TÀ35 and T+360 Paired score differences between TÀ7 and T+360 n m (s) P n m (s) P Abbreviations: HRQL ¼ health-related quality of life; NS ¼ no significant difference. A minus mean difference means that the score at T+360 is higher (in terms of better HRQL) than the score at TÀ35 and TÀ7, respectively.
Child reports
Although different measures were used, our study replicated the results of Phipps et al. 10, 11 The worst HRQL was seen shortly after transplant and HRQL thereafter improved steadily until 6 months after BMT. However, the observed standard deviations and score ranges suggest that not all patients drew benefit from this average favorable evolution. Further, except for nausea, the improvement seemed not to be linear, as minor drawbacks could be observed in nearly all HRQL domains between two consecutive measurement time points after T þ 28. As compared to 6 months after BMT, HRQL was better in only three domains of the parent reports at 1 year after BMT. This may reflect the disappointment about ongoing symptoms and about the strict medical surveillance, but also the fact that certain problems do not resolve after T þ 180.
Nevertheless, as compared to pre-BMT, a remarkable and significant amelioration can be expected 1 year after BMT. This is in concordance with the findings of Phipps et al. 11 and Barrera et al, 9 although they used 6 months instead of 1 year after BMT as end points. However, these positive results on a group level should not disguise the number of patients who do worse than the average. The mean generic HRQL score of physical, emotional, social and school functioning at T þ 360 was 81, and about 20% of patients showed a score of p70 (range 32-70). There was a strong association between physical and psychosocial functioning, suggesting that those who do not do well physically also suffer from psychosocial problems. Therefore, some kind of psychosocial service for these patients should be seen as a necessary and integral part of long-term follow-up care. 22 Some studies have identified pre-BMT functioning to be predictive of post-BMT functioning. 8, 9, 23 In an attempt to find out which HRQL problems during the acute phase of treatment were associated with HRQL 1 year after BMT, we identified three major predictor variables: emotional functioning, worry and communication. Levels of pain and nausea during the acute phase of treatment did not have an impact on HRQL 1 year after BMT. These findings suggest that compromised emotional functioning, a high level of worry and reduced communication during the stay at the transplant unit do not only have an immediate adverse effect on the patient's status, but may negatively affect outcome in a number of HRQL domains. This points to the need to target interventions more specifically to reduce these problems before they become persistent. There are a number of techniques available that may have potential benefits. 24 Interventional research, although notoriously difficult, should evaluate which techniques are most successful in reducing patient suffering and enhancing HRQL.
Our data illustrate the transient somatic and psychological distress that occurs in response to the demanding therapy. They also confirm clinical observations. For example, it is hardly surprising that the HRQL of patients is worst shortly after transplantation. 11 Nevertheless, we should not relinquish taking an individualized approach in Table 3 Interobserver agreement between children, resident parents, second parents (available only for TÀ35 and T+360) and physicians about the child's HRQL assessed with PedsQLt and HUI the care of patients, as those who do relatively well medically, may suffer from other problems. HRQL data can therefore serve as a measure to identify patients who need targeted support at a specific time point with the aim to improve their current situation as well as to decrease the risk for long-term adverse effects on their HRQL. After some debate about whether it is possible and advisable to ask the children directly about their HRQL, there is common agreement that the views of adults and children may be discordant, and that adults (parents, physicians, nurses, etc.) cannot reliably be used as proxyinformants in relation to the child's own experience of the condition. 21 However, during intensive treatment, it is imperative to be aware of patients' problems, even when they are not openly communicated, in order to arrange appropriate medical and/or psychosocial support. Therefore, it is important to be able to rely on the reports of proxies about the child's feelings and condition. HRQL assessment from different viewpoints may be one useful tool for ascertaining when, and among which assessors the largest discrepancies between child and proxy reports occur.
Our results on interobserver agreement of patients, resident parents and physicians were twofold: first, HRQL scores of child reports were significantly higher in about one-third of assessments in terms of better HRQL and less problems than that of parent reports. Scores of the physician reports were generally in-between child-and parent-report scores. Second, correlation analyses revealed that, despite the differences in score levels, the concordance between child and parent reports was altogether moderate to good. The best agreement was seen when the HRQL of the children was the worst, that is, 10 days after BMT. Child-physician agreement was poor shortly before and after transplantation and also 3 months later, and was generally lower than parent-physician agreement.
For interpretation, the results of two other studies in pediatric BMT recipients are noteworthy: Phipps et al. 10 obtained very similar symptom trajectories across the hospitalization from reports of children, parents and nurses. Interobserver correlations were generally in the low to moderate range, with better agreement among patients and parents than among patients and nurses. Parsons et al. 25 conducted a cross-sectional study of 82 school-aged pediatric BMT patients and assessed their HRQL by using self-and proxy-versions of the 'Child Health Rating Inventories (CHRIs)' and the 'Disease Impairment Inventories -Bone Marrow Transplant (DSIII-BMT)'. The children's self-reported health status correlated significantly with the physicians' disease severity rating across all generic and disease-specific domains. In contrast, the parental reports of child health status did not correlate significantly with disease severity ratings for disease-specific problems or the child's pain. As in our study, parental ratings were significantly lower than the children's ratings. The longer the time interval between BMT and assessment, the smaller the deviations between parents' and children's responses.
Ours and Phipps et al.'s 10 results seem to contradict the findings of Parsons et al. 25 as far as the agreement of child and health-care team member is concerned. However, Parsons et al. 25 conducted a cross-sectional study and their sample was very heterogeneous with regard to the time elapsed since BMT, the range being 40-3000 days. Therefore, their results may be only applicable to patients after intensive treatment. In fact, child-parent-health care team member agreement was shown to be quite good in childhood cancer patients, on average a couple of years off treatment and coming to regular medical routine checkups to the clinic. 15, 20 During intensive treatment, physicians may be reluctant to recognize patients' problems that are beyond medical control and therefore under-or overestimate HRQL deficits in the individual patient. Lee et al. 26 conducted a survey of physicians' attitudes about HRQL issues in BMT recipients. Most physicians regarded information about HRQL as being important, but believed that their patients and caregivers are willing to accept a poor HRQL for even a small chance of cure. This may have an effect on physicians' attitudes toward HRQL issues. Further, during periods of increased vulnerability and stress, it is often very difficult to approach patients with direct communication, which, in turn, makes the estimation of the patient's real condition more difficult.
Although parents' estimations of their child's HRQL may be colored by their own fears and expectations, and scores in parent reports are therefore systematically lower than scores in child reports, parents can be generally considered as good and reliable informants. Their concerns expressed during parent-physician encounters should therefore be taken seriously, especially during critical phases of treatment.
In summary, our study showed that the majority of pediatric patients who are treated successfully with BMT can expect a good HRQL 1 year post transplant. HRQL assessment seems to be a sensitive method to depict the various psychological and physical stressors patients and families are confronted with. Certain HRQL deficits during intensive therapy may negatively affect HRQL 1 year later. These should therefore be considered as a subject for psychological intervention. Our findings may be useful for the information of patients and families before transplant and for the planning of specific interventions during BMT therapy. Future work from our research group will present and discuss the role of resilience promoting and other factors, such as age, disease status and source of transplant, for the HRQL of pediatric BMT recipients.
